Risers and Fallers
FTSE 250 movers: Genus soars on FDA green light; Mobico tanks again
By Frank Prenesti
Date: Wednesday 30 Apr 2025
(Sharecast News) - FTSE 250 (MCX) 19,755.34 -0.27%
Animal genetics company Genus surged after the US Food and Drug Administration (FDA) approved its PRP gene edit under its PRRS Resistant Pig ("PRP") programme for use in the U.S. food supply chain.
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
Article Archive
You are here: news
